PolyNovo Clinical Trials Update
Filed with ASX ·
Watch Polynovo's latest callPolynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Polynovo
- Trading halt and request
- Topical Negative Pressure Human Trial Completed
- Positive Results from NovoSorb Human Clinical Trial
- AOD9604 Positive in Osteoarthritis Animal Model
- RAH Surgeons Receive Approval to use BTM
Later from Polynovo
- CZD: Termination of Metabolic vend-in proposal
- Feasibility Study Extended by 12 Months
- NovoSkin awarded BioInnovationSA Grant
- US Regulatory Update
- Additional BARDA Option Exercised Valued at US$2.4m
Follow Polynovo into a list and get an email when it puts out news.
Follow Polynovo